R. Gilbert

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).

D. Price, M. Mugford, E. Juniper, 2011, Health technology assessment.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

D. Price, E. Juniper, L. Shepstone, 2011, The New England journal of medicine.